Jurisdiction
发表于 2025-3-21 18:07:00
书目名称Cancer Chemo- and Immunopharmacology影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0221067<br><br> <br><br>书目名称Cancer Chemo- and Immunopharmacology读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0221067<br><br> <br><br>
背书
发表于 2025-3-22 00:16:45
http://reply.papertrans.cn/23/2211/221067/221067_2.png
郊外
发表于 2025-3-22 01:53:13
https://doi.org/10.1007/978-3-642-67931-5 drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.
homocysteine
发表于 2025-3-22 06:06:12
Psychosomatische Störung und Neuroseolid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
潜伏期
发表于 2025-3-22 10:05:06
https://doi.org/10.1007/978-3-319-47542-4of the testes, but also in ovarian carcinoma, in melanoma, and in epidermoid carcinoma, especially of the head and of the uterus cervix. Its toxicity, manifested mainly in the digestive and renal tracts, confines its administration to hospitalized patients only. This compound is now indicated in combination therapy for the above-mentioned tumors.
CLAY
发表于 2025-3-22 15:03:56
http://reply.papertrans.cn/23/2211/221067/221067_6.png
CLAY
发表于 2025-3-22 17:17:12
N-(Phosphonacetyl)-,-Aspartate (PALA): Current Status,olid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.
欢腾
发表于 2025-3-22 23:41:42
http://reply.papertrans.cn/23/2211/221067/221067_8.png
承认
发表于 2025-3-23 05:06:02
Bedingungen neurotischer EntwicklungThe inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.
aspect
发表于 2025-3-23 06:09:22
Clinical Chemotherapy: Its Correlation with Experimental Models,The inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.